Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Dupuytren's Disease

Known as: Dupuytren Disease, Dupuytrens Disease 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Individuals with Dupuytren disease (DD) are commonly seen by physicians and surgeons across multiple specialties. It is an… Expand
  • figure 1
  • table 1
  • figure 2
2016
2016
PURPOSE The course of Dupuytren disease (DD) is thought to be progressive; however, the course differs for each patient. The… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
2014
2014
PURPOSE To compare long-term outcomes and retreatment rates for patients with Dupuytren disease who underwent needle aponeurotomy… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 4
2013
2013
PURPOSE To explore the impact of Dupuytren disease (DD) from the patients' perspective. METHODS Audio-recorded interviews were… Expand
2013
2013
PURPOSE To study the evolution of deformity of the proximal interphalangeal joint over 5 years after good surgical correction of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
2013
2013
PURPOSE To determine the effect of a specific orthotic intervention and therapy protocol on proximal interphalangeal (PIP) joint… Expand
  • figure 1
  • figure 2
  • table 1
2012
2012
PURPOSE Dupuytren disease (DD) is a benign fibrosing disorder of the hand and fingers. Recently, we identified 9 single… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
2010
2010
  • A. Bayat
  • Nature Reviews Rheumatology
  • 2010
  • Corpus ID: 10737669
Surgery is the current mainstay of treatment for Dupuytren disease but is associated with potentially serious complications and a… Expand
2009
2009
The active cellular component in Dupuytren disease (DD) is the α-smooth muscle actin (α-SMA) containing myofibroblast. The… Expand
Highly Cited
2003
Highly Cited
2003
Transforming growth factor &bgr;1 (TGF-&bgr;1) is a key fibrogenic cytokine that has been shown to stimulate fibroblast… Expand